Management of orthopaedic surgery in rare bleeding disorders

Area of Science:

• Orthopaedic Surgery
• Hematology
• Rare Bleeding Disorders

Background:

• Limited knowledge exists on managing orthopaedic surgery in patients with rare bleeding disorders (RBDs).
• Retrospective analysis of 35 orthopaedic procedures in 22 RBD patients (1982-2013).

Purpose of the Study:

• To evaluate hemostatic management strategies and outcomes for orthopaedic surgery in patients with rare bleeding disorders.
• To identify factors influencing successful surgical outcomes in this patient population.

Main Methods:

• Retrospective data collection and analysis of 35 orthopaedic procedures in 22 patients with RBD.
• Review of heterogeneous hemostatic therapy regimens, including replacement therapy, fresh frozen plasma (FFP), recombinant activated factor VII, and tranexamic acid.
• Analysis of bleeding complications and thromboembolism prophylaxis.

Main Results:

• Bleeding complications occurred in 7 of 35 procedures (20%).
• Satisfactory hemostasis control was achieved in most patients.
• Hemostatic treatment may be avoidable in some mild factor deficiency cases (FVII, FXI).

Conclusions:

• Successful orthopaedic surgery in RBD patients requires meticulous hemostasis control and adequate surgical technique.
• Involvement of specialized hemophilia centers is crucial for optimal patient management.
• Further research into optimized hemostatic strategies for rare bleeding disorders is warranted.